Ed Schoonveld

The Price of Global Health (eBook, PDF)

Drug Pricing Strategies to Balance Patient Access and the Funding of Innovation

• Format: PDF

Produktbeschreibung

The Price of Global Health is a unique book that describes the pharmaceutical pricing process and its business, economic and social challenges. Global drug pricing is one of the most hotly debated yet least understood aspects of the pharmaceutical industry. How should drug prices be set and what does it mean for patients? Why do governments increasingly get involved, and what is its impact on the global competitive environment? How can a life-saving industry have a poorer image than gun and tobacco industries, whose products are associated with death?

The pharmaceutical industry is under unprecedented pressure due to a combination of declining R&D productivity, payer/provider demands for better value and public pressures to show pricing restraint. Rapidly increasing cost of healthcare, shifts from fee-for-service to value-based reimbursement, public pressure on drug pricing and an increasingly vocal medical community have empowered public and private payers worldwide to be more demanding on evidence of value for the prescription drugs that are brought to market. Pharmaceutical companies have often failed to deliver evidence of patient value, as development decision-making is overly focused on speed to FDA approval rather than speed to commercial success by effectively addressing the many "Access Journey" obstacles that typify today's much changed pharmaceutical environment.

This 3rd edition is significantly expanded with ten new chapters and revised and updated throughout to reflect today's environment. The contents are reorganized to directly address critical pricing and patient access issues. Ed Schoonveld explains how pharmaceutical prices are determined in a complex global payer environment and what factors influence the process. His insights will help a wide range of audiences from healthcare industry professionals to policy makers, consumers, pharmaceutical company leaders and access and pricing professionals to gain a better understanding of this highly complex and emotionally charged field.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis
• Seitenzahl: 626
• Erscheinungstermin: 17. Mai 2020
• Englisch
• ISBN-13: 9781000050639
• Artikelnr.: 59482888

Autorenporträt

Ed Schoonveld has 30+ years of experience in pharmaceutical pricing and access. He is currently Managing Partner of the Value and Access Practice with ZS Associates. He led global pricing functions for Wyeth, Lilly and BMS and consulting practices in Cambridge Pharma/IMS and Analytica International.

Inhaltsangabe

List of Figures
List of Tables
List of Abbreviations
Foreword by Andrea Mantovani
Acknowledgements
Preface
About the Author
Introduction
Part A The Challenges of Drug Pricing and Market Access
1 Why is drug pricing different? 2 The Age of Value and Affordability
3 The Access Journey
4 Fair Pricing
Part B Traveling the Access Journey
5 Payers
6 Medical Community
7 Provider Organizations
8 Patients
Part C Pricing and Payer Management Techniques
9 Fundamentals of Pricing
10 Reference-Based Pricing
11 Health Economics and Outcomes Research
12 Attributes
Benefits
Value and Price
Part D Structured Access and Pricing Approaches
13 Pricing and Drug Development
14 Payer Segmentation
15 The PODiUM Framework
16 BEST Framework
17 Development Options and Decisions
18 Value Story and Messaging
Part E Developing an Integrated Global Strategy
19 Developing a Global Pricing Strategy
20 Public Policy
21 Oncology and Orphan Drugs
22 Gene Therapy Pricing and Funding
23 Biosimilars
24 Payer and Pricing Research
Part F Access and Pricing Strategy Implementation
25 Organizing for Access
26 Access and Price Negotiations
27 Value-based Agreements
28 Creating Win-Win Deals
Part G Key Health Care Systems
29 United States
30 Canada
31 France
32 Germany
33 Italy
34 Spain
35 United Kingdom
36 Japan
37 Australia
38 Brazil
39 China
40 India
41 South Korea
References
Index